Hugo W. Tilanus - Concepedia

Author

Hugo W. Tilanus

Also Known As

B P L Wijnhoven, B P L Wijnhoven , Bas P.L. Wijnhoven, H Metselaar, H TILANUS, H Tilanus, H W TILANUS, H W Tilanus, H W. Tilanus, H. Tilanus

320

Publications

22.8K

Citations

H-Index

161

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam Rotterdam University of Applied Sciences Amsterdam UMC Location University of Amsterdam University of Amsterdam

About

Hugo W. Tilanus is an author at Erasmus MC specializing in medicine, surgery, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	87	10K
2	Health Sciences	10	10	762
3	Engineering	2	2	47
4	Nursing	1	1	52
5	Public Health	1	1	43

Hugo W. Tilanus

196

Publications

21.9K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, The Lancet Oncology Surgical OncologyNeoadjuvant ChemoradiotherapyEsophageal CancerGastrointestinal OncologyMedicine	2015	2.5K
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus Jan B.F. Hulscher, Johanna W. van Sandick, Angela G. E. M. de Boer, New England Journal of Medicine	2002	1.6K
Extended Lymph-Node Dissection for Gastric Cancer Johannes J. Bonenkamp, J. Hermans, Mitsuru Sasako, New England Journal of Medicine	1999	1.6K
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Johannes J. Bonenkamp, Ilfet Songun, K Welvaart, The Lancet Surgical OncologyD2 DissectionGastrointestinal OncologyMedicineGastroenterology	1995	1K
Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial H.H. Hartgrink, C.J.H. van de Velde, Hein Putter, Journal of Clinical Oncology	2004	920
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Journal of Clinical Oncology	2021	709
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus Jikke M.T. Omloo, Sjoerd M. Lagarde, Jan B.F. Hulscher, Annals of Surgery	2007	705
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial Marjolein Y.V. Homs, Ewout W. Steyerberg, Wilhelmina M.H. Eijkenboom, The Lancet Surgical OncologySurgeryOesophageal CancerMedicineRadiation Oncology	2004	504
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells Vedashree Ramakrishnaiah, Christine Thumann, Isabel Fofana, Proceedings of the National Academy of Sciences Viral ReplicationHepatitis C VirusViral PathogenesisImmunologyPathology	2013	487
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction Marinke Westerterp, Linetta B. Koppert, Christianne J. Buskens, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Surgical OncologyEsophagusEsophageal CancerSurgical TreatmentGastroenterology	2005	332

Page 1